샘플 요청 목록

 카트 문의
시장보고서
상품코드
1797208

세계의 심장 임플란트 시장

Cardiac Implants
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 388 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장 임플란트 시장은 2030년까지 578억 달러에 도달

2024년에 375억 달러로 추정되는 세계의 심장 임플란트 시장은 분석 기간인 2024-2030년에 CAGR 7.5%로 성장하며, 2030년에는 578억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 이식형 제세동기는 CAGR 9.4%를 기록하며, 분석 기간 종료시에는 164억 달러에 달할 것으로 예측됩니다. 페이스메이커 분야의 성장률은 분석 기간 중 CAGR 8.6%로 추정됩니다.

미국 시장은 102억 달러, 중국은 CAGR 11.9%로 성장 예측

미국의 심장 임플란트 시장은 2024년에 102억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 124억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간2024-2030년 CAGR은 11.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.6%와 7.3%로 예측됩니다. 유럽에서는 독일이 CAGR 4.9%로 성장할 것으로 예측됩니다.

세계의 심장 임플란트 시장 - 주요 동향과 촉진요인 정리

심장 임플란트가 심혈관 질환 관리의 중심이 되는 이유는 무엇인가?

심장 임플란트는 광범위한 심혈관 질환의 치료 및 관리에서 생명을 구하고 생명을 강화하는 의료기기로서 점점 더 많이 사용되고 있습니다. 부정맥, 관상동맥질환, 심부전 등 심장 관련 질환의 세계 부담이 지속적으로 증가하는 가운데, 이러한 임플란트는 정상적인 심장 기능을 회복하고 환자의 생존율을 향상시키는 데 매우 중요한 역할을 하고 있습니다. 심장 임플란트에는 심박조율기, 이식형 제세동기(ICD), 심장재동기화요법(CRT) 기기, 심실보조장치(VAD)(VAD), 심장판막 등 다양한 기기가 포함됩니다. 이들은 각각 불규칙한 심장 박동을 조절하거나 약해진 심장을 기계적으로 지지하는 등 특수한 기능을 수행합니다. 전 세계에서 고령화, 좌식 생활과 식습관 악화로 인해 심혈관 질환이 급증하고 있으며, 효과적인 치료법의 필요성이 높아지고 있습니다. 심장 임플란트는 치료적 이점뿐만 아니라 원격 모니터링 기능을 통한 진단 능력을 제공하여 의사가 환자의 심장 기능을 실시간으로 추적하고 적시에 임상적 판단을 내릴 수 있도록 도와줍니다. 또한 최소 침습 수술에 대한 수요는 외과적 외상이 적고 회복이 빠른 차세대 임플란트의 채택을 촉진하고 있습니다. 많은 말기 심장병 환자들에게 임플란트는 이식을 대체할 수 있는 유일한 대안입니다. 선진국과 신흥 경제국 모두 조기 진단에 대한 인식이 높아지고 의료 기술에 대한 접근성이 향상됨에 따라 심장 임플란트는 현대 심혈관 치료 전략에 필수적인 요소로 자리 잡고 있습니다.

기술 혁신은 현대 심장 임플란트의 디자인과 기능을 어떻게 형성하고 있는가?

기술의 발전은 심장 임플란트를 더 작고, 더 똑똑하고, 더 효과적으로 빠르게 변화시키고 있습니다. 가장 주목할 만한 개발 중 하나는 장치의 소형화로, 보다 최소 침습적인 임플란트를 가능하게 하고 환자의 편안함을 향상시키는 것입니다. 이 소형 임플란트는 또한 배터리 수명이 길고 전력 효율이 향상되어 잦은 교체가 필요하지 않습니다. 무선통신과 블루투스 지원 텔레메트리가 내장되어 실시간 원격 모니터링이 도입되어 임플란트에서 의사의 모니터링 시스템으로 지속적인 데이터 전송이 가능해졌습니다. 이러한 연결성은 진단의 정확도를 높일 뿐만 아니라, 기기 고장이나 환자 상태 악화시 적극적인 개입을 가능하게 합니다. AI 알고리즘과 데이터 분석 플랫폼은 현재 심장 리듬을 분석하고, 합병증을 예측하고, 치료를 개인화하기 위해 통합되고 있습니다. 리드리스 스페이스메이커의 등장은 기존의 리드에 따른 합병증을 해결하고, 감염과 기계적 고장의 위험을 줄였습니다. 생체적합성 소재와 첨단 코팅 기술은 염증 반응을 억제하고 장기적인 기능성을 향상시켜 임플란트의 안전성 프로파일을 더욱 향상시켰습니다. 심부전 환자들에게 차세대 심실보조장치(VAD)은 소형화, 저소음화되어 일상 생활에 더 적합하고 심리적 고통도 줄일 수 있게 되었습니다. 또한 생체흡수성 스카라폴드 및 조직공학 심장판막의 획기적인 발전으로 인해, 특히 소아 및 기존 기구를 졸업한 젊은 환자에서 시간이 지남에 따라 몸에 자연스럽게 적응할 수 있는 임플란트의 길이 열리고 있습니다. 또한 로봇을 이용한 이식 수술의 혁신으로 수술의 정확도가 향상되고 수술 시간이 단축되고 있습니다. 기술이 계속 발전함에 따라 심장 임플란트는 치료뿐만 아니라 환자의 고유한 요구에 적응하고, 학습하고, 예측할 수 있도록 설계되고 있습니다.

세계 심장 임플란트 수요는 어떤 지역과 인구통계학적 패턴이 주도하고 있는가?

심장 임플란트에 대한 세계 수요는 지역별 헬스케어 역학, 인구통계학적 변화, 질병 유행 패턴의 조합에 영향을 받고 있습니다. 북미, 특히 미국과 캐나다는 높은 심혈관 질환 비율, 높은 의료 인프라 및 유리한 상환 정책으로 인해 심장 임플란트의 주요 시장으로 부상하고 있습니다. 유럽은 독일, 프랑스, 영국 등이 조기 진단 및 중재적 심장학에 많은 투자를 하고 있으며, 이식형 기기의 보급이 활발히 이루어지고 있습니다. 아시아태평양에서는 급속한 도시화, 라이프스타일의 변화, 고혈압, 당뇨병, 비만 증가가 심장병 환자의 급증에 기여하고 있습니다. 중국, 인도, 일본 등의 국가에서는 도시와 농촌을 막론하고 심장 치료 시설을 확대하려는 정부의 구상과 함께 의료비 증가를 볼 수 있습니다. 치료법에 대한 인식과 접근성이 향상됨에 따라 이들 국가는 심장 임플란트 제조업체에게 유망 시장으로 부상하고 있습니다. 라틴아메리카와 중동 일부 지역에서는 민간 의료 부문의 확대와 의료 관광이 수요 증가를 촉진하고 있지만, 일부 지역에서는 높은 장비 비용과 제한된 상환이 장벽으로 작용하고 있습니다. 노인은 부정맥, 심부전, 판막의 퇴행성 질환에 걸리기 쉽기 때문입니다. 그러나 선천성 심장병이나 유전적 질환을 가진 젊은 환자들도 장기 사용과 합병증 발생률을 낮추기 위해 고안된 새로운 임플란트 기술의 혜택을 받고 있습니다. 심혈관계 검진 프로그램 및 전문 의료 센터의 확대는 진단율을 더욱 높이고 있으며, 이는 모든 연령대와 지역에서 임플란트 식립량 증가와 직결되어 있습니다.

세계 심장 임플란트 시장의 성장을 가속하는 주요 요인은?

심장 임플란트 시장의 성장은 역학 동향, 기술 혁신, 의료 인프라, 환자 기대치의 변화를 중심으로 몇 가지 강력한 힘에 의해 주도되고 있습니다. 우선, 인구 고령화와 비만, 흡연, 당뇨병과 같은 생활습관 관련 위험 요인에 의해 심혈관 질환의 전 세계 유병률이 증가함에 따라 임플란트와 같은 중재적 솔루션에 대한 요구가 지속적으로 증가하고 있습니다. 동시에, 무심장박동기, 스마트 센서, MRI 지원 기기 등 임플란트 기술의 개선이 진행되어 심장 기기의 임상 범위와 안전성 프로파일이 확대되고 있습니다. 최소침습수술의 활성화도 수요에 영향을 미치고 있습니다. 새로운 임플란트 디자인은 빠른 회복과 입원 기간 단축을 가능하게 하며, 이는 가치 기반 의료 시스템에서 점점 더 중요한 지표가 되고 있습니다. 원격의료 및 원격 모니터링 기술의 확대로 임플란트 치료 후 관리 및 순응도가 향상되어 장기적인 치료 성공률이 높아지고 있습니다. 조기 치료 옵션에 대한 환자와 임상의의 인식이 높아짐에 따라 조기 진단과 조기 임플란트 시술이 가능해져 환자 예후가 개선되고 있습니다. 신흥 시장에서는 헬스케어 투자 확대, 보험 접근성 향상, 심장 전문센터 설립으로 더 많은 환자들이 임플란트를 포함한 시술을 받을 수 있게 되었습니다. 또한 심혈관계 사망률 감소에 초점을 맞춘 정부 및 비정부 의료 구상은 광범위한 검진 및 기기 기반 치료에 대한 자금 지원을 지원하고 있습니다. 마지막으로 의료기기 회사와 의료 서비스 프로바이더와의 전략적 파트너십을 통해 유통, 교육 및 시판 후 지원을 개선하여 이전에는 충분히 침투하지 못했던 시장에서 임플란트 도입이 가속화되고 있습니다. 이러한 요인들이 결합되어 세계 심장 임플란트 시장의 지속적인 확장을 보장하고 현재와 미래의 심혈관 치료에서 중요한 역할을 강화하고 있습니다.

부문

제품(이식형 제세동기, 페이스메이커, 관상동맥 스텐트, 이식형 심박 모니터, 이식형 혈행동태 모니터, 기타 제품), 용도(부정맥 용도, 급성 심근경색 용도, 심근허혈 용도, 기타 용도), 최종사용자(병원 최종사용자, 순환기 센터 최종사용자, 기타 최종사용자)

조사 대상 기업의 예

  • Abiomed, Inc.
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Cook Medical Incorporated
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.
  • Johnson & Johnson(Ethicon/BIOL)
  • Lepu Medical Technology Co., Ltd.
  • LivaNova plc
  • Medico S.p.A.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Zimmer Biomet Holdings, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.09.02

Global Cardiac Implants Market to Reach US$57.8 Billion by 2030

The global market for Cardiac Implants estimated at US$37.5 Billion in the year 2024, is expected to reach US$57.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Implantable Cardioverter-defibrillators, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$16.4 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Cardiac Implants market in the U.S. is estimated at US$10.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.4 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Cardiac Implants Market - Key Trends & Drivers Summarized

Why Are Cardiac Implants Becoming Central to the Management of Cardiovascular Disorders?

Cardiac implants are increasingly being adopted as life-saving and life-enhancing medical devices in the treatment and management of a wide spectrum of cardiovascular diseases. As the global burden of heart-related conditions such as arrhythmias, coronary artery disease, and heart failure continues to rise, these implants are playing a pivotal role in restoring normal cardiac function and improving patient survival rates. Cardiac implants encompass a diverse range of devices including pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and heart valves. Each of these serves a specialized function, from regulating irregular heartbeats to providing mechanical support for weakened hearts. The growing prevalence of aging populations across the world, coupled with increasingly sedentary lifestyles and poor dietary habits, has contributed to a surge in cardiovascular ailments, further elevating the need for effective interventions. Cardiac implants offer not only therapeutic benefits but also diagnostic capabilities through remote monitoring features, allowing physicians to track a patient’s heart function in real time and make timely clinical decisions. The demand for minimally invasive procedures is also bolstering the adoption of newer-generation implants that require less surgical trauma and offer faster recovery. For many patients with end-stage heart disease, implants represent the only viable alternative to transplantation. The growing awareness of early diagnosis and the improved accessibility of healthcare technologies in both developed and emerging economies continue to make cardiac implants an integral component of modern cardiovascular care strategies.

How Are Technological Innovations Shaping the Design and Functionality of Modern Cardiac Implants?

Technological advancements are rapidly transforming the landscape of cardiac implants, making them smaller, smarter, and significantly more effective. One of the most notable developments is the miniaturization of devices, allowing for less invasive implantation and improved patient comfort. These smaller implants also come with longer battery lives and enhanced power efficiency, reducing the need for frequent replacements. The incorporation of wireless communication and Bluetooth-enabled telemetry has introduced real-time remote monitoring, enabling continuous data transmission from the implant to the physician’s monitoring system. This connectivity is not only enhancing diagnostic precision but also allowing for proactive intervention in cases of device malfunction or patient deterioration. AI algorithms and data analytics platforms are now being integrated to analyze heart rhythms, anticipate complications, and personalize treatment. The emergence of leadless pacemakers has addressed complications associated with traditional leads, offering reduced risk of infection and mechanical failure. Biocompatible materials and advanced coating technologies have further improved the safety profile of implants by reducing inflammatory responses and improving long-term functionality. For patients with heart failure, new-generation VADs are now smaller and quieter, making them more suitable for daily life and reducing psychological distress. Additionally, breakthroughs in bioresorbable scaffolds and tissue-engineered heart valves are paving the way for implants that can be naturally integrated into the body over time, particularly in pediatric or younger patients who outgrow traditional devices. Innovations in robotic-assisted implantation techniques are also improving procedural accuracy and reducing operation times. As technology continues to evolve, cardiac implants are increasingly being designed not only to treat but also to adapt, learn, and predict patient-specific needs.

What Regional and Demographic Patterns Are Driving Global Demand for Cardiac Implants?

The global demand for cardiac implants is being influenced by a combination of regional healthcare dynamics, demographic shifts, and disease prevalence patterns. In North America, particularly in the United States and Canada, high rates of cardiovascular disease combined with advanced healthcare infrastructure and favorable reimbursement policies have made the region a leading market for cardiac implants. Europe follows closely, with countries such as Germany, France, and the UK investing heavily in early diagnosis and interventional cardiology, thereby maintaining robust adoption of implantable devices. In Asia-Pacific, rapid urbanization, lifestyle changes, and increasing incidence of hypertension, diabetes, and obesity are contributing to a sharp rise in heart disease cases. Countries like China, India, and Japan are witnessing growing healthcare expenditures, along with government initiatives to expand cardiac care facilities in both urban and rural areas. As awareness and access to treatment improve, these countries are emerging as high-potential markets for cardiac implant manufacturers. In Latin America and parts of the Middle East, expanding private healthcare sectors and medical tourism are facilitating increased demand, although high device costs and limited reimbursement remain barriers in certain areas. Demographically, the aging global population is a key demand driver, as older adults are significantly more susceptible to arrhythmias, heart failure, and valve degeneration. However, younger patients with congenital heart defects or genetic conditions are also benefiting from new implant technologies designed for long-term use and lower complication rates. The widening reach of cardiovascular screening programs and specialist care centers is further increasing the diagnosis rates, which directly correlates with higher implant volumes across all age groups and regions.

What Are the Key Drivers Propelling Growth in the Global Cardiac Implants Market?

The growth in the cardiac implants market is driven by several powerful forces centered around epidemiological trends, technological innovation, healthcare infrastructure, and shifting patient expectations. First and foremost, the rising global prevalence of cardiovascular diseases, fueled by aging populations and lifestyle-related risk factors such as obesity, smoking, and diabetes, is creating a consistently high need for interventional solutions like implants. Simultaneously, ongoing improvements in implant technology, including leadless pacemakers, smart sensors, and MRI-compatible devices, are expanding the clinical scope and safety profile of cardiac devices. The push for minimally invasive procedures is also influencing demand, as new implant designs allow for faster recovery and reduced hospital stays, which are increasingly important metrics in value-based healthcare systems. The expansion of telemedicine and remote monitoring technologies is facilitating better post-implant care and compliance, increasing the long-term success rates of these interventions. Increased awareness among both patients and clinicians regarding early treatment options is resulting in earlier diagnosis and implant intervention, improving patient outcomes. In emerging markets, growing healthcare investments, improved access to insurance, and the establishment of cardiac specialty centers are enabling more patients to undergo procedures involving implants. Moreover, government and non-government health initiatives focusing on reducing cardiovascular mortality are supporting widespread screening and funding for device-based treatment. Finally, strategic partnerships between medical device companies and healthcare providers are improving distribution, training, and post-market support, accelerating the adoption of implants in previously underpenetrated markets. Together, these factors are ensuring sustained expansion of the global cardiac implants market, reinforcing its critical role in contemporary and future cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Cardiac Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors, Other Products); Application (Arrhythmias Application, Acute Myocardial Infarction Application, Myocardial Ischemia Application, Other Applications); End-User (Hospitals End-Users, Cardiology Centers End-Users, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abiomed, Inc.
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Cook Medical Incorporated
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.
  • Johnson & Johnson (Ethicon/BIOL)
  • Lepu Medical Technology Co., Ltd.
  • LivaNova plc
  • Medico S.p.A.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Cardiac Implants as Life-Saving Interventions
    • Increasing Aging Population Spurs Demand for Long-Term Implantable Solutions for Heart Rhythm and Structural Disorders
    • Here's the Story: How Advancements in Minimally Invasive Procedures Are Expanding Access to Cardiac Implant Therapies
    • Technological Innovations in Pacemakers, Defibrillators, and Heart Valves Strengthen Business Case for Next-Gen Devices
    • Growth in Transcatheter and Leadless Implant Technologies Fuels Market Expansion Across Risk Categories
    • Here's How Remote Monitoring and Smart Implants Are Reshaping Post-Operative Cardiac Care
    • Rising Adoption of Left Ventricular Assist Devices (LVADs) and Artificial Hearts Drives Demand in Advanced Heart Failure Management
    • Global Expansion of Electrophysiology Labs and Structural Heart Programs Supports Implant Procedure Volumes
    • Growing Awareness and Screening Initiatives Drive Early Diagnosis and Prophylactic Implantation
    • Rising Burden of Lifestyle-Related Risk Factors Fuels Preventive Use of Cardiac Rhythm Management Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Implantable Cardioverter-defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Implantable Heart Rhythm Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Implantable Hemodynamic Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Acute Myocardial Infarction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Myocardial Ischemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hospitals End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Cardiology Centers End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: France 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: India 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제